Safety and delay time in prehospital thrombolysis of acute myocardial infarction in urban and rural areas in Sweden

American Journal of Emergency Medicine

Volumn 21, Issue 4, 2003, Pages 263-270

  Svensson, Leif ^a   Karlsson, Thomas ^b   Nordlander, Rolf ^a   Wahlin, Magnus ^c   Zedigh, Crister ^d   Herlitz, Johan ^b  

^a STOCKHOLM SÖDER HOSPITAL   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c NU Hospital Organisation   (Sweden)

^d FALUN HOSPITAL   (Sweden)

Author keywords

Acute myocardial infarction; Prehospital thrombolysis

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; RETEPLASE;

ACUTE HEART INFARCTION; ADULT; AGED; AMBULANCE; ARTICLE; BLEEDING; BLOOD CLOT LYSIS; BOLUS INJECTION; CARDIOGENIC SHOCK; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEALTH CARE PERSONNEL; HEART EJECTION FRACTION; HEART FAILURE; HOSPITAL ADMISSION; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MEDICAL STAFF; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPONSE TIME; RURAL AREA; ST SEGMENT ELEVATION; SWEDEN; URBAN AREA;

EID: 0042575113     PISSN: 07356757     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-6757(03)00040-8     Document Type: Article

References (17)

1. ISIS-1 (first International Study of Infarct Survival) Collaborative Group: Randomised trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction - ISIS-1. Lancet 1986;2:57-65
2. GISSI (Gruppo Italiano per lo Studieo della Streptochinasi nell' Infarto miocardio): Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;i:397-401
3. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group: Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomised trials of more than 100 patients. Lancet 1994;343:311-322
4. Great Group: Feasibility, safety, and efficacy of domiciliary thrombolysis by general practitioners: Grampian Region Early Anistreplase Trial. BMJ 1992;305:548-553
5. Svensson L, Karlsson T, Nordlander R, Wahlin M, Zedigh C, Herlitz J: Implementation of prehospital thrombolysis in Sweden. Components of delay until delivery of treatment and feasibility. Intern J Cardiol 2003;88:247-256.
6. Swedish Working Group on Early Heart Attack Care: A survey of treatment routines and educational level of health care providers in the initial phase of suspected acute myocardial infarction in Sweden in 1994. Eur J Emerg Med 1996;3:149-156
7. Boersma E, Maas ACP, Deckers JW, Simoons ML: Early thrombolytic treatment in acute myocardial infarction: Reappraisal of the golden hour. Lancet 1996;348:771-775
8. Morrison LJ, Werbeek PR, McDonald AC, Sawadsky BV, Cook DJ. Mortality and prehospital thrombolysis to acute myocardial infarction. A meta-analysis. JAMA 2000;283:2686-2692
9. Lamfers EJP, Hooghoudt TEH, Uppelschoten A, Stolwijk PWJ, Verheugt FWA: Effect of prehospital thrombolysis in aborting acute myocardial infarction. Am J Cardiol 1999;84:928-930
10. Arntz HR, Stern R, Linderer T: Efficiency of a physician-operated mobile intensive care unit for prehospital thrombolysis in acute myocardial infarction. Am J Cardiol 1992;70:417-420
11. BEPS Collaborative Group: Prehospital thrombolysis in acute myocardial infarction: the Belgian eminase prehospital study (BEPS). Eur Heart J 1991;12:965-967
12. Rozenman Y, Gotsman MS, Weiss AT, et al: Early intravenous thrombolysis in acute myocardial infarction: The Jerusalem experience. Int J Cardiol 1995;49:521-528 (suppl)
13. Barbash GI, Roth A, Hod H, et al: Improved survival but not left ventricular function with early and prehospital treatment with plasminogen activator in acute myocardial infarction. Am J Cardiol 1990;66:261-266
14. Castaigne AD, Herve C, Duval-Moulin AM, et al: Prehospital use of APSAC: Results of a placebocontrolled study. Am J Cardiol 1989;64:30A-3A (suppl)
15. Roth A, Barbash GI, Hod M, et al: Should thrombolytic therapy be administrated in the mobile intensive care unit in patients with evolving myocardial infarction? A pilot study. J Am Coll Cardiol 1990;15:932-936
16. Herlitz J, Hjalmarson Å, Holmberg S, Richter A, Wennerblom B: Mortality and morbidity in suspected acute myocardial infarction in relation to ambulance transport. Eur Heart J 1987;8:503-509
17. RIKS-HIA: Annual Report 2000. www.riks-hia.c.se